Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Arm Study to Assess the Safety and Efficacy of a Single Treatment of BOTOX, Followed by an Optional Open-Label Treatment With BOTOX, in Female Subjects With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
Conditions
Interventions
BOTOX
Placebo for BOTOX
Locations
43
United States
Urology Centers of Alabama /ID# 243600
Homewood, Alabama, United States
Urology Associates of Mobile, PA /ID# 255854
Mobile, Alabama, United States
Alliance for Multispecialty Research (AMR) - Mobile /ID# 241002
Mobile, Alabama, United States
Sun Kim Urology /ID# 257566
Buena Park, California, United States
Cedars-Sinai Medical Center /ID# 245786
Los Angeles, California, United States
University of California, Los Angeles /ID# 245131
Los Angeles, California, United States
Start Date
March 29, 2022
Primary Completion Date
July 5, 2024
Completion Date
December 6, 2024
Last Updated
May 6, 2025
Lead Sponsor
AbbVie
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions